High-Dose Biotin Fails in MS Trial

(MedPage Today) -- High-dose pharmaceutical-grade biotin (MD1003) did not significantly improve disability or walking speed in patients with progressive multiple sclerosis (MS), the phase III SPI2 trial showed.
About 12% of patients treated with...